"Hooked on" prescription-type opiates prior to using heroin: Results from a survey of syringe exchange clients

Journal of Psychoactive Drugs

Volumn 44, Issue 3, 2012, Pages 259-265

  Peavy, K Michelle ^a   Banta Green, Caleb J ^a   Kingston, Susan ^b   Hanrahan, Michael ^b   Merrill, Joseph O ^a   Coffin, Phillip O ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c Public Health Seattle and King County ^*  (United States)

Author keywords

Heroin; Pharmaceutical opioids; Syringe exchange; Trajectory

Indexed keywords

ALPRAZOLAM; BUPRENORPHINE; CARISOPRODOL; CLONAZEPAM; COCAINE; DIAMORPHINE; DIAZEPAM; HYDROCODONE BITARTRATE PLUS PARACETAMOL; METHADONE; METHAMPHETAMINE; OPIATE; OXYCODONE; SEDATIVE AGENT;

ADULT; ARTICLE; DRUG DEPENDENCE; DRUG USE; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HEROIN DEPENDENCE; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SELF REPORT; SYRINGE; UNITED STATES;

ADULT; ANALGESICS, OPIOID; DATA COLLECTION; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; NARCOTICS; NEEDLE-EXCHANGE PROGRAMS; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; SYRINGES; WASHINGTON;

EID: 84868144927     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2012.704591     Document Type: Article

References (32)

1. Ahmed, S. H.; Walker, J. & Koob, G. 2000. Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 22 (4): 413-21.
2. Banta-Green, C. J.; Maynard, C.; Koepsell, T.; Wells, E. & Donovan, D. 2009a. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction 104 (5): 775-783.
3. Banta-Green, C.; Merrill, J.O.; Doyle, S.; Boudreau, D.M. & Calsyn, D.A. 2009b. Measurement of opioid problems among chronic pain patients in a general medical population. Drug and Alcohol Dependence 104: 43-49.
4. Banta-Green, C.; Jackson, T.R.; Albert, D.; Taylor, M.; Hanrahan, M.; Sookup, M.; Ohta, J.; Freng, S.; Smith, R.; Forbes, A. & Harruff, R. 2009c. Recent drug abuse trends in Seattle-King County. Presented at the National Institute on Drug Abuse's Community Epidemiology Work Group Meeting, Chicago, IL, June 11.
5. Booth, B.M.; Leukefeld, C.; Falck, R.; Wang, J. & Carlson, R. 2006. Correlates of rural methamphetamine and cocaine users: Results from a multistate community study. Journal of Studies on Alcohol 67 (4): 493-501.
6. Canfield, M.C.; Keller, C.; Frydrych, L.; Ashrafioun, L.; Purdy, C. & Blondell, R. 2010. Prescription opioid use among patients seeking treatment for opioid dependence. Journal of Addiction Medicine 4 (2): 108-13.
7. Catalano, R.F.; White, H.; Fleming, C. & Haggerty, K. 2011. Is nonmedical prescription opiate use a unique form of illicit drug use? Addictive Behaviors 36 (1-2): 79-86.
8. Chen, S.A.; O'Dell, L.; Hoefer, M.; Greenwell, T.; Zorrilla, E. & Koob, G. 2006. Unlimited access to heroin self-administration: Independent motivational markers of opiate dependence. Neuropsychopharmacology 31 (12): 2692-2707.
9. Compton, W.A & Volkow, N. 2006. Abuse of prescription drugs and the risk of addiction. Drug and Alcohol Dependence 83: S4-S7.
10. Daniulaityte, R.; Carlson, R. & Kenne, D. 2006. Initiation to pharmaceutical opioids and patterns of misuse: Preliminary qualitative findings obtained by the Ohio Substance Abuse Monitoring Network. Journal of Drug Issues 36 (4): 787-808.
11. Degenhardt, L.; Black, E.; Breen, C.; Bruno, R.; Kinner, S.; Roxburgh, A.; Fry, C.; Jenkinson, R.; Ward, J.; Fetherston, J.; Weekley, J. & Fischer, J. 2006. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug & Alcohol Review 25: 403-12.
12. Drug Enforcement Administration (DEA). 2009. 2008 Heroin Domestic Monitoring Program. DEA Publication 09022. Arlington, VA: DEA.
13. Drug Enforcement Administration (DEA). 1998-2006. Department of Justice, Drug Enforcement Administration ARCOS 2- Report 1 Retail drug distribution by zip code. Available at: http://www.deadiversion.usdoj.gov/arcos/retail_drug_summary/index.html
14. Fischer, B.; Patra, J.; Cruz, M.F.; Gittins, J. & Rehm, J. 2008. Comparing heroin users and prescription opioid users in a Canadian multisite population of illicit opioid users. Drug & Alcohol Review 27: 625-32.
15. Fountain, J.; Strang, J.; Gossop, M.; Farrel, M. & Griffiths, P. 2000. Diversion of prescribed drugs by drug users in treatment: Analysis of the UK market and new data from London. Addiction 95: 393-406.
16. Hansen, R.N.; G. Oster, G.; Edelsberg, J.; Woody, G. & Sullivan, S. 2011. Economic costs of nonmedical use of prescription opioids. Clinical Journal of Pain 27 (3): 194-202.
17. Hosmer, D.W. & Lemeshow, S. 2000. Applied Logistic Regression, Second Ed. New York: Wiley Inter-science.
18. Koob, G.F. 2009. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 56: 18-31.
19. Lenoir, M. & Ahmed, S. 2008. Supply of a nondrug substitute reduces escalated heroin consumption. Neuropsychopharmacology 33 (9): 2272-82.
20. Levy, M.S. 2007. An exploratory study of OxyContin use among individuals with substance use disorders. Journal of Psychoactive Drugs 39 (3): 271-76.
21. McCabe, S.E.; Boyd, C. & Young, A. 2007. Medical and nonmedical use of prescription drugs among secondary school students. Journal of Adolescent Health 40 (1): 76-83.
22. National Institute on Drug Abuse (NIDA). 2005. NIDA Research Report Series: Heroin Abuse and Addiction. NIH Publication Number 05-4165. Washington, DC: US Department of Health and Human Services.
23. Paulozzi, L.J.; Budnitz, D.S. & Xi, Y. 2006. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology and Drug Safety 15 (9): 618-27.
24. Pollini, R.; Banta-Green, C.J.; Cuevas-Mota, J.; Metzner, M.; Teshale, E. & Garfein, R.S. 2011. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Substance Abuse and Rehabilitation 2 (1): 173-80.
25. Rosenblum, A., M. Parrino, M.; S. H. Schnoll, S.; Fong, C.; Maxwell, C; Cleland, C.; Magura, S. & Haddox, J. 2007. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence 90 (1): 64-71.
26. Sabel, J. & Banta-Green, C.J. 2009. Prescription pain killer abuse among teens in Washington State. Presented at the Council of State and Territorial Epidemiologists, Buffalo, NY, June 9.
27. Sjogren, P. & Hojsted, J. 2007. Addiction to opioids in chronic pain patients: A literature review. European Journal of Pain 11 (5): 490-518.
28. Subramaniam, G.A. & Stitzer, M.A. 2009. Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder. Drug and Alcohol Dependence 101: 13-19.
29. Substance Abuse and Mental Health Services Administration (SAMHSA). 2007. Results from the 2006 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293. Rockville, MD: SAMHSA.
30. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (SAMHSA). 2009. Treatment Episode Data Set, 2009. Highlights - 2007. National Admissions to Substance Abuse Treatment Services, DASIS Series: S-45, DHHS Publication No. (SMA) 09-4360, Rockville, MD: SAMHSA.
31. Walker, J. R.; Chen, S.; Moffitt, H.; Inturrisi, C. & Koob, G. 2003. Chronic opioid exposure produces increased heroin self-administration in rats. Pharmacology Biochemistry and Behavior 75 (2): 349-54.
32. Wu, L.T.; Woody, G.; Yang, C. & Blazer, D. 2011. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Addiction Medicine 5 (1): 28-35.